State of the science: Uterine carcinosarcomas: From pathology to practice

CONCLUSION: Ongoing endometrial cancer clinical trials now include UCS patients. In combination with advances in molecular profiling, this will provide patients with UCS improved therapeutic options. Until that time, surgical resection and traditional cytotoxic chemotherapy remains standard of care.PMID:34030871 | DOI:10.1016/j.ygyno.2021.05.003

Source: Gynecologic Oncology - May 25, 2021 Category: Cancer & Oncology Authors: Michael D Toboni Erin K Crane Jubilee Brown Alexander Shushkevich Sarah Chiang Brian M Slomovitz Douglas A Levine Sean C Dowdy Ann Klopp Matthew A Powell Premal H Thaker Source Type: research